Floatz logo

Fluconazole

Systemic Mycosis

Radboud University Medical CenterSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Systemic Mycosis cohort.

Asset / SponsorPhaseRating
Isavuconazole
Astellas Pharma Inc
Phase 3BB
Oxygen
Jay C. Buckey Jr.
Phase 4BB
Fosmanogepix
Basilea Pharmaceutica
Phase 2CCC
Micafungin
Astellas Pharma Europe B.V.
UnknownD

Same molecule, other indications

Fluconazole is also rated in:

candidiasis, invasiveActive
BB
Indicative · Phase 4
69 / 100
View asset →
infectious diseaseDormant
BB
Indicative · Phase 3
64 / 100
View asset →
fungal infectious diseaseActive
BB
Indicative · Phase 3
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →